Monte Rosa Therapeutics annual revenue
2022
2023
2024
2025
Monte Rosa Therapeutics Revenue Growth & History (GLUE)
Monte Rosa Therapeutics reported $123.7M in revenue for fiscal 2025, an increase of 63.54% from the previous fiscal year.
View full Monte Rosa Therapeutics company overviewMonte Rosa Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $123.7M | $48.0M | +63.54% |
| 2024 | 2024-12-31 | $75.6M | $75.6M | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | — | — |
Monte Rosa Therapeutics quarterly revenue
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $9.0M | −$14.2M | −61.33% |
| Q1 2026 | 2026-03-31 | $4.2M | −$80.7M | −95.04% |
| Q4 2025 | 2025-12-31 | $2.8M | −$57.9M | −95.41% |
| Q3 2025 | 2025-09-30 | $12.8M | $3.6M | +38.54% |
| Q2 2025 | 2025-06-30 | $23.2M | $18.5M | +394.01% |
| Q1 2025 | 2025-03-31 | $84.9M | $83.9M | +7882.05% |
| Q4 2024 | 2024-12-31 | $60.6M | $60.6M | — |
| Q3 2024 | 2024-09-30 | $9.2M | $9.2M | — |
| Q2 2024 | 2024-06-30 | $4.7M | $4.7M | — |
| Q1 2024 | 2024-03-31 | $1.1M | $1.1M | — |
| Q4 2023 | 2023-12-31 | $0 | — | — |
| Q3 2023 | 2023-09-30 | $0 | — | — |
| Q2 2023 | 2023-06-30 | $0 | — | — |
| Q1 2023 | 2023-03-31 | $0 | — | — |
Monte Rosa Therapeutics revenue growth trends
Monte Rosa Therapeutics's latest reported quarter, Q2 2026, generated $9.0M in revenue, a decrease of 61.33% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Monte Rosa Therapeutics source filings ↗